#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	16	96	ANT_2____Ia	750	210	100.0	ANT_2____Ia.l15.c30.ctg.1	438	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	266	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1053	13.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	307	309	ACG	13;13;14	A;C;G	13;13;14	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	A888G	SNP	888	888	A	8	8	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	C897G	SNP	897	897	C	17	17	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	T898C	SNP	898	898	T	18	18	C	9	C	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	G906T	SNP	906	906	G	26	26	T	14	T	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	G908A	SNP	908	908	G	28	28	A	16	A	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	A918T	SNP	918	918	A	38	38	T	18	T	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	A943G	SNP	943	943	A	63	63	G	42	G	41	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	212	Chlamydophila_psittaci_16S	1507	115	92.17	Chlamydophila_psittaci_16S.l15.c17.ctg.1	115	20.7	0	.	n	.	0	G991T	SNP	991	991	G	111	111	T	21	T	21	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	1124	Escherichia_coli_EF_Tu	1185	1027	99.71	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1027	45.9	0	HET	.	.	.	C216T	.	216	216	C	81	81	C	49	C,T	31,18	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	1124	Escherichia_coli_EF_Tu	1185	1027	99.71	Escherichia_coli_EF_Tu.l15.c30.ctg.1	1027	45.9	0	HET	.	.	.	C951A	.	951	951	C	816	816	C	50	C,A	27,23	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	1124	Escherichia_coli_EF_Tu	1185	184	98.37	Escherichia_coli_EF_Tu.l15.c30.ctg.3	192	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	1124	Escherichia_coli_EF_Tu	1185	72	100.0	Escherichia_coli_EF_Tu.l15.c30.ctg.4	216	9.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	165	1124	Escherichia_coli_EF_Tu	1185	164	98.78	Escherichia_coli_EF_Tu.l15.c30.ctg.5	164	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	374	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1648	11.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1561	1563	AAA	6;6;5	A;A;A	6;6;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	536	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c17.ctg.1	1790	15.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1246	1248	GAA	22;21;20	G;A;A	22;21;20	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	84	H_NS	414	414	99.03	H_NS.l15.c30.ctg.2	428	8.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Mrx.3003839.AY522923.1.7744_8983.3600	Mrx.3003839.AY522923.1.7744_8983.3600	1	0	27	400	Mrx	1239	1239	100.0	Mrx.l15.c4.ctg.1	1306	14.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Mrx;Part of the macrolide inactivation gene cluster in Aeromonas hydrophila
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	432	PmrB_1	1092	1076	99.16	PmrB_1.l15.c30.ctg.1	1322	16.8	0	.	p	.	0	H2R	NONSYN	4	6	CAT	248	250	CGT	9;9;8	C;G;T	9;8;8	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	432	PmrB_1	1092	1076	99.16	PmrB_1.l15.c30.ctg.1	1322	16.8	0	.	p	.	0	V30I	NONSYN	88	90	GTC	332	334	ATC	19;18;18	A;T;C	19;18;18	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	531	432	PmrB_1	1092	1076	99.16	PmrB_1.l15.c30.ctg.1	1322	16.8	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1091	1093	GGC	22;22;22	G;G;C	21;22;21	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	628	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1795	18.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	115	117	AGC	4;4;5	A;G;C	4;4;5	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	628	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1795	18.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	517	519	CTA	20;20;20	C;T;A	20;20;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	628	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1795	18.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1036	1038	CAA	28;28;29	C;A;A	28;28;29	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	628	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1795	18.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1135	1137	GGT	27;28;27	G;G;T	27;28;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	628	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	1795	18.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1705	1707	GTT	11;11;10	G;T;T	11;11;10	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	242	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1486	8.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	528	530	GAA	6;6;6	G;A;A	6;6;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	242	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1486	8.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	708	710	ACC	3;3;3	A;C;C	3;3;3	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	242	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1486	8.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	828	830	ACT	6;6;6	A;C;T	6;6;6	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	242	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1486	8.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1218	1220	ATC	3;4;4	A;T;C	3;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	358	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1206	15.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	424	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1034	16.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	996	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3427	15.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	469	471	ATC	8;9;9	A;T;C	8;9;9	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	996	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3427	15.5	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1462	1464	ATC	10;11;10	A;T;C	10;11;10	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	996	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3427	15.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2182	2184	AAG	8;8;8	A;A;G	8;8;8	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	432	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1568	14.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	273	275	GTC	5;5;5	G;T;C	5;5;5	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	432	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1568	14.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1014	1016	TGC	23;23;22	T;G;C	23;23;22	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	914	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2794	17.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	177	177	T	9	T	9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	914	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2794	17.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	483	485	GAC	19;18;18	G;A;C	19;18;17	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	914	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2794	17.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	759	761	TTA	9;9;9	T;T;A	9;9;9	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	914	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2794	17.1	0	.	p	.	0	D301N	NONSYN	901	903	GAT	942	944	AAT	8;8;8	A;A;T	8;8;8	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	914	acrF	3105	2598	98.04	acrF.l15.c4.ctg.1	2794	17.1	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1729	1729	T	25	T	25	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	250	acrR_2	648	648	99.54	acrR_2.l6.c30.ctg.1	1075	12.3	1	SNP	p	R45C	0	.	.	133	135	CGC	332	334	CGC	26;26;25	C;G;C	26;26;25	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	190	acrS	663	663	98.64	acrS.l15.c4.ctg.1	919	10.7	0	.	p	.	0	L34F	NONSYN	100	102	CTC	188	190	TTC	6;6;6	T;T;C	6;6;6	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	190	acrS	663	663	98.64	acrS.l15.c4.ctg.1	919	10.7	0	.	p	.	0	E122G	NONSYN	364	366	GAG	452	454	GGG	14;13;13	G;G;G	14;13;13	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	194	adiY	762	762	99.61	adiY.l15.c4.ctg.1	960	9.7	0	.	p	.	0	V136L	NONSYN	406	408	GTT	560	562	CTT	14;14;14	C;T;T	14;14;14	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1070	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3001	19.1	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2012	2014	GCA	27;28;28	G;C;A	27;28;28	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1070	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3001	19.1	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2273	2275	ACC	29;30;28	A;C;C	29;29;27	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1070	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3001	19.1	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2582	2584	GCC	21;20;21	G;C;C	21;20;21	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	G37A	NONSYN	109	111	GGT	176	178	GCT	2;2;2	G;C;T	2;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	D77E	NONSYN	229	231	GAT	296	298	GAG	8;8;7	G;A;G	8;8;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	332	334	TGC	7;6;6	T;G;C	7;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	515	517	GTT	13;13;13	G;T;T	13;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	665	667	CAC	15;15;15	C;A;C	15;15;15	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	950	952	ATG	16;17;17	A;T;G	16;17;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	546	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2241	12.6	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1946	1948	CGC	8;8;10	C;G;C	7;8;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	232	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1015	11.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	791	793	ACC	7;6;6	A;C;C	7;6;6	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	232	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1015	11.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	803	805	TCG	8;9;9	T;C;G	8;9;9	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	16	178	baeR	723	521	97.5	baeR.l15.c30.ctg.1	775	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	342	baeS	1404	1404	98.79	baeS.l6.c30.ctg.1	1759	10.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1284	1286	AAA	5;5;5	A;A;A	4;5;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	342	baeS	1404	1404	98.79	baeS.l6.c30.ctg.1	1759	10.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1296	1298	GAG	8;8;8	G;A;G	7;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	342	baeS	1404	1404	98.79	baeS.l6.c30.ctg.1	1759	10.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1302	1304	CAC	9;9;10	C;A;C	9;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	342	baeS	1404	1404	98.79	baeS.l6.c30.ctg.1	1759	10.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1356	1358	GAG	8;8;7	G;A;G	8;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	27	248	TEM_1+	861	861	100.0	TEM_1+.l15.c4.ctg.1	1018	11.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	19	508	cpxA	1374	1251	99.04	cpxA.l15.c30.ctg.1	1451	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	310	cpxR	699	699	99.43	cpxR.l6.c4.ctg.1	1087	15.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	214	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1206	9.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	602	604	ACT	10;10;10	A;C;T	10;10;10	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	176	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	802	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
dfrA14.3002859.EU780012.2162_2645.206	dfrA14.3002859.EU780012.2162_2645.206	1	0	539	126	dfrA14	483	483	99.79	dfrA14.l15.c30.ctg.1	815	8.2	0	.	p	.	0	I9M	NONSYN	25	27	ATA	171	173	ATG	7;7;7	A;T;G	7;7;7	.	dfrA14;dfrA14 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	394	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1216	16.1	0	.	p	.	0	I219V	NONSYN	655	657	ATC	679	681	GTC	28;25;24	G;T;C	28;24;24	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	616	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	1995	16.5	0	.	p	.	0	E197K	NONSYN	589	591	GAA	819	821	AAA	15;15;14	A;A;A	15;15;14	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	382	emrD	1191	1097	98.36	emrD.l15.c4.ctg.1	1314	13.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	842	844	AGC	14;14;13	A;G;C	14;14;13	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	382	emrD	1191	96	98.96	emrD.l15.c4.ctg.3	179	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	14	emrE_1	333	94	96.81	emrE_1.l15.c4.ctg.1	94	4.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	242	emrK	1056	889	98.2	emrK.l15.c4.ctg.1	954	9.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	591	593	AGG	5;5;6	A;G;G	5;5;6	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	513	242	emrK	1056	145	98.62	emrK.l15.c4.ctg.2	302	8.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	5	7	GAC	4;4;4	G;A;C	4;4;4	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	224	emrR	531	531	100.0	emrR.l15.c4.ctg.1	943	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	410	emrY	1539	1539	99.81	emrY.l6.c4.ctg.1	1942	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	156	evgA	615	615	99.19	evgA.l6.c30.ctg.1	952	8.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	411	413	CTG	8;8;8	C;T;G	8;8;8	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	200	202	ATA	4;4;4	A;T;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	212	214	GTA	4;4;4	G;T;A	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	365	367	ACG	6;7;7	A;C;G	6;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	428	430	GAA	6;6;6	G;A;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	467	469	GCT	14;14;14	G;C;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	485	487	GAT	10;11;11	G;A;T	10;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	572	574	TCA	9;9;9	T;C;A	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	701	703	CAG	6;7;6	C;A;G	6;7;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	839	841	GTT	7;6;6	G;T;T	7;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	N303D	NONSYN	907	909	AAT	995	997	GAT	6;6;6	G;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1163	1165	AAT	4;4;4	A;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1184	1186	TTA	3;3;3	T;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1385	1387	AAA	2;2;3	A;A;A	2;2;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2120	2122	CAT	7;7;7	C;A;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2174	2176	CAT	4;4;4	C;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2192	2194	AGA	5;5;5	A;G;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2207	2209	AAT	8;8;8	A;A;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2354	2356	TCC	4;3;3	T;C;C	4;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2519	2521	ATT	7;7;7	A;T;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2540	2542	GAT	7;7;7	G;A;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2654	2656	GTT	14;14;12	G;T;T	14;14;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	728	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	3905	9.9	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	2939	2941	CAC	4;4;4	C;A;C	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	300	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1240	12.7	1	SNP	p	P64A	0	.	.	190	192	CCA	398	400	CCA	22;22;24	C;C;A	21;22;24	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	300	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1240	12.7	1	SNP	p	P64S	0	.	.	190	192	CCA	398	400	CCA	22;22;24	C;C;A	21;22;24	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	300	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1240	12.7	1	SNP	p	P64L	0	.	.	190	192	CCA	398	400	CCA	22;22;24	C;C;A	21;22;24	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	300	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1240	12.7	1	SNP	p	P64R	0	.	.	190	192	CCA	398	400	CCA	22;22;24	C;C;A	21;22;24	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	300	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1240	12.7	1	SNP	p	P64H	0	.	.	190	192	CCA	398	400	CCA	22;22;24	C;C;A	21;22;24	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	138	gadE	528	528	100.0	gadE.l15.c30.ctg.1	937	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	95	97.89	gadW.l6.c4.ctg.1	95	11.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	103	105	ATG	2;2;2	A;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	106	108	CCG	2;1;1	C;C;G	2;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	139	141	GAA	2;2;2	G;A;A	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	142	144	TCC	2;2;2	T;C;C	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	145	147	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	56	gadW	729	294	93.2	gadW.l6.c4.ctg.3	297	3.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	169	171	AAT	1;2;2	A;A;T	1;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	170	gadX	825	819	97.92	gadX.l6.c30.ctg.1	906	9.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	244	246	TTA	8;7;7	T;T;A	8;7;7	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	170	gadX	825	819	97.92	gadX.l6.c30.ctg.1	906	9.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	322	324	ATT	6;6;6	A;T;T	6;6;6	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	170	gadX	825	819	97.92	gadX.l6.c30.ctg.1	906	9.2	0	.	p	.	0	R246G	NONSYN	736	738	AGA	823	825	GGA	10;10;10	G;G;A	10;10;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	170	gadX	825	819	97.92	gadX.l6.c30.ctg.1	906	9.2	0	.	p	.	0	S248P	NONSYN	742	744	TCG	829	831	CCG	9;9;9	C;C;G	9;9;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2217	2219	GAA	15;15;16	G;A;A	15;15;16	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	S83W	0	.	.	247	249	TCG	432	434	TCG	15;15;15	T;C;G	15;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	S83I	0	.	.	247	249	TCG	432	434	TCG	15;15;15	T;C;G	15;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	S83L	0	.	.	247	249	TCG	432	434	TCG	15;15;15	T;C;G	15;15;15	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	D87G	0	.	.	259	261	GAC	444	446	GAC	17;18;18	G;A;C	17;17;18	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	D87N	0	.	.	259	261	GAC	444	446	GAC	17;18;18	G;A;C	17;17;18	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	D87H	0	.	.	259	261	GAC	444	446	GAC	17;18;18	G;A;C	17;17;18	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	D87V	0	.	.	259	261	GAC	444	446	GAC	17;18;18	G;A;C	17;17;18	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	958	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3024	16.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	444	446	GAC	17;18;18	G;A;C	17;17;18	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136G	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136H	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136L	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136E	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136S	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136I	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	712	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2618	14.0	1	SNP	p	R136C	0	.	.	406	408	CGC	557	559	CGC	11;11;10	C;G;C	11;11;10	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	186	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1089	9.1	0	.	p	.	0	A72P	NONSYN	214	216	GCG	448	450	CCG	16;16;16	C;C;G	16;16;16	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	186	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1089	9.1	0	.	p	.	0	T123A	NONSYN	367	369	ACC	601	603	GCC	11;11;12	G;C;C	11;11;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	326	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1291	13.4	0	.	p	.	0	P9S	NONSYN	25	27	CCA	187	189	TCA	9;11;12	T;C;A	9;11;12	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	122	marA	384	384	99.74	marA.l6.c4.ctg.1	682	8.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	V45E	0	.	.	133	135	GTG	141	143	GTG	8;10;10	G;T;G	6;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	I49S	0	.	.	145	147	ATC	153	155	ATC	13;13;13	A;T;C	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	A70T	0	.	.	208	210	GCA	216	218	GCA	12;12;12	G;C;A	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	R73S	0	.	.	217	219	CGT	225	227	CGT	13;12;12	C;G;T	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	R73C	0	.	.	217	219	CGT	225	227	CGT	13;12;12	C;G;T	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	R77L	0	.	.	229	231	CGC	237	239	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	R77C	0	.	.	229	231	CGC	237	239	CGC	10;9;9	C;G;C	10;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	270	98.52	marR.l15.c30.ctg.1	278	8.4	1	SNP	p	L78M	0	.	.	232	234	CTG	240	242	CTG	9;8;8	C;T;G	9;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	141	96.45	marR.l15.c30.ctg.2	141	2.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	16	18	AGC	1;1;1	A;G;C	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	76	marR	435	141	96.45	marR.l15.c30.ctg.2	141	2.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	118	120	CAT	2;2;2	C;A;T	2;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	64	66	ATC	5;5;5	A;T;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	82	84	GCC	2;2;2	G;C;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	85	87	GTG	3;3;3	G;T;G	3;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	112	114	GAT	4;4;4	G;A;T	3;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	133	135	ACC	3;3;3	A;C;C	3;2;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	160	162	TTA	6;6;6	T;T;A	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	301	303	CAG	11;11;12	C;A;G	11;11;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	340	342	GCC	10;9;9	G;C;C	10;8;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	445	447	GCG	8;8;8	G;C;G	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	649	651	GTT	11;11;11	G;T;T	9;11;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	284	mdfA	1233	1191	96.98	mdfA.l15.c4.ctg.1	1382	10.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	811	811	C	11	C	11	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	646	97.99	mdtA.l15.c4.ctg.1	646	11.7	0	.	p	.	0	P257T	NONSYN	769	771	CCG	190	192	ACG	8;8;8	A;C,A;G	8;7,1;8	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	646	97.99	mdtA.l15.c4.ctg.1	646	11.7	0	.	p	.	0	T404P	NONSYN	1210	1212	ACC	631	633	CCC	6;6;6	C,A;C;C	0,3;6;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	570	96.49	mdtA.l15.c4.ctg.2	671	6.7	0	.	p	.	0	V12trunc	TRUNC	34	34	G	141	141	G	13	G	13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	570	96.49	mdtA.l15.c4.ctg.2	671	6.7	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	198	200	CAG	5;5;5	C;A;G	5;5;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	570	96.49	mdtA.l15.c4.ctg.2	671	6.7	0	.	p	.	0	T83I	NONSYN	247	249	ACC	348	350	ATC	10;10;10	A;T;C	10;10;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	570	96.49	mdtA.l15.c4.ctg.2	671	6.7	0	.	p	.	0	I99M	NONSYN	295	297	ATA	396	398	ATG	5;5;5	A;T;G	5;5;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	513	266	mdtA	1248	570	96.49	mdtA.l15.c4.ctg.2	671	6.7	0	.	p	.	0	A130T	NONSYN	388	390	GCC	489	491	ACC	8;7;7	A;C;C	8;7;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1984	1986	ACC	15;15;15	A;C;C	15;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2377	2379	CAA	9;10;10	C;A;A	9;10;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2545	2547	ATT	11;10;10	A;T;T	11;10;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2629	2631	GTT	8;8;8	G;T;T	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2737	2739	GAG	8;8;8	G;A;G	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2965	2967	ATG	8;8;8	A;T;G	8;8;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	531	950	mdtB	3123	3080	99.06	mdtB.l6.c30.ctg.1	3317	15.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3100	3102	GAT	11;12;14	G;A;T	11;11;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	956	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3225	15.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	233	235	ATG	9;9;9	A;T;G	9;9;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	956	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3225	15.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	719	721	ATC	13;14;15	A;T;C	13;14;15	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	956	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3225	15.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3035	3037	CAC	2;2;1	C;A;C	2;2;1	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	956	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3225	15.5	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3038	3040	CTC	1;1;2	C;T;C	1;1;2	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	394	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1602	12.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	170	172	GAA	8;8;8	G;A;A	8;8;8	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	394	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1602	12.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	839	841	GCG	15;15;15	G;C;G	15;15;15	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	394	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1602	12.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1181	1183	ATC	14;14;14	A;T;C	14;14;14	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	394	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1602	12.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1484	1486	TTT	15;17;18	T;T;T	15;17;18	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	448	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1615	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1132	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3534	17.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1051	1053	ACC	20;20;19	A;C,A;C	20;17,2;19	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1132	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3534	17.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2293	2295	GAC	27;25;25	G,A;A;C	26,1;23;24	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	528	398	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1424	12.9	0	.	p	.	0	V200I	NONSYN	598	600	GTC	562	564	ATC	19;19;19	A;T;C,T	19;19;18,1	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	348	mdtH	1209	1201	98.17	mdtH.l15.c30.ctg.1	1290	13.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	392	394	TGT	15;15;12	T;G;T	15;15;12	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	348	mdtH	1209	1201	98.17	mdtH.l15.c30.ctg.1	1290	13.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	962	964	TTG	9;9;9	T;T;G	9;9;9	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	348	mdtH	1209	1201	98.17	mdtH.l15.c30.ctg.1	1290	13.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1172	1174	ACG	7;7;7	A;C;G	7;7;7	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	412	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1618	13.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	796	798	TCC	11;11;10	T,G;C;C	10,1;11;10	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	338	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1315	13.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	427	429	ATT	17;15;15	A;T;T	17;14;15	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	55	57	ATG	9;8;8	A;T;G	9;8;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	121	123	ATC	11;11;12	A;T;C	11;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	370	372	CGC	24;23;23	C;G;C	23;23;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	736	738	AGC	15;13;14	A;G;C	15;13;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	937	939	GTG	12;12;12	G;T;G	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1000	1002	AAC	8;9;9	A;A;C	8;6;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1045	1047	GTC	14;14;14	G;T;C	14;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1075	1077	ATA	15;15;15	A;T;A	15;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1183	1185	TCT	13;14;15	T;C;T	13;14;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1570	1572	GCG	21;20;21	G;C;G	21;20;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	590	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2134	14.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1783	1785	ATC	9;10;9	A;T;C	9;10;9	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	S129A	NONSYN	385	387	TCA	470	472	GCG	11;11;11	G;C;G	11;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	A187T	NONSYN	559	561	GCC	644	646	ACC	13;13;13	A;C;C	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	H211R	NONSYN	631	633	CAC	716	718	CGC	16;16;17	C,A;G;C	15,1;16;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	V250A	NONSYN	748	750	GTT	833	835	GCT	17;17;17	G;C;T	17;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	R278K	NONSYN	832	834	AGA	917	919	AAA	10;10;11	A;A;A	10;10;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	935	937	CGA	16;16;16	C;G;A	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1100	1102	GCC	7;7;7	G;C;C	7;7;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1112	1114	GAT	10;10;10	G;A;T	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	412	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1597	13.1	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1529	1531	GCT	5;5;5	G;C;T	5;5;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1166	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3871	16.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1520	1522	AAG	12;12;11	A;A;G	12;12;11	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1166	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3871	16.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2597	2599	CTG	20;20;20	C;T;G	20;20;20	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	76	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	164	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
mphA.3000316.AJ698325.6453_7359.647	mphA.3000316.AJ698325.6453_7359.647	1	0	539	298	mphA	906	906	99.78	mphA.l15.c4.ctg.1	1268	12.2	0	.	p	.	0	A299S	NONSYN	895	897	GCA	1130	1132	TCA	3;3;3	T,G;C;A	0,1;1;2	.	The mphA gene encodes for resistance enzyme MPH(2')-I which preferentially inactivate 14-membered macrolides (e.g.erythromycin, telithromycin, roxithromycin) over 16-membered macrolides (e.g.tylosin, spiramycin). It phosphorylates macrolides at 2'-OH hydroxyl of desosamine sugar of macrolides in a GTP-dependent manner.;mphA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	586	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1991	15.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1019	1021	AAC	11;12;12	A;A;C	11;11;12	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	586	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1991	15.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1565	1567	ATA	12;13;12	A;T;A	12;13;12	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	470	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1567	15.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1320	1322	GAT	20;20;20	G;A;T	20;20;20	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	470	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1567	15.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1323	1325	CTG	20;20;22	C;T;G	20;20;22	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	136	nfsA	723	405	99.01	nfsA.l6.c4.ctg.1	741	9.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	178	180	TGT	10;10;10	T;G;T	10;10;10	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	136	nfsA	723	405	99.01	nfsA.l6.c4.ctg.1	741	9.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	448	450	ACC	13;13;12	A;C;C	13;13;12	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	136	nfsA	723	405	99.01	nfsA.l6.c4.ctg.1	741	9.5	1	SNP	p	R15C	0	.	.	43	45	CGC	142	144	CGC	15;16;16	C;G;C	15;16;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	136	nfsA	723	405	99.01	nfsA.l6.c4.ctg.1	741	9.5	1	SNP	p	S33R	0	.	.	97	99	AGC	196	198	AGC	5;4;4	A;G;C	5;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	136	nfsA	723	405	99.01	nfsA.l6.c4.ctg.1	741	9.5	1	SNP	p	G131D	0	.	.	391	393	GGC	490	492	GGC	7;6;6	G;G;C	7;6;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	0	.	p	.	0	M2K	NONSYN	4	6	ATG	44	46	AAG	2;2;2	A;A,T;G	2;0,1;2	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	0	.	p	.	0	D312E	NONSYN	934	936	GAT	974	976	GAG	15;15;15	G;A;G	15;15;15	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	1	SNP	p	G141D	0	.	.	421	423	GGT	461	463	GGT	22;21;22	G;G;T	22;21;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	1	SNP	p	G141E	0	.	.	421	423	GGT	461	463	GGT	22;21;22	G;G;T	22;21;22	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	1	SNP	p	R154D	0	.	.	460	462	CGT	500	502	CGT	18;18;19	C;G;T	18;18;19	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	382	ompF	1089	1089	99.82	ompF.l6.c30.ctg.1	1303	15.0	1	SNP	p	R154A	0	.	.	460	462	CGT	500	502	CGT	18;18;19	C;G;T	18;18;19	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1890	1892	GTG	19;21;21	G;T;G	19;21;21	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1917	1919	TCG	13;13;13	T;C;G	11;12;12	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2532	2534	AAC	18;18;17	A;A;C	17;18;17	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	1	SNP	p	A85T	0	.	.	253	255	GCG	546	548	GCG	22;22;22	G;C;G	20;21;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	1	SNP	p	D111H	0	.	.	331	333	GAT	624	626	GAT	15;15;16	G;A;T	15;14;16	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	930	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2630	18.6	1	SNP	p	S129P	0	.	.	385	387	TCC	678	680	TCC	16;16;15	T;C;C	15;16;15	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	474	parE_1	1893	1752	97.37	parE_1.l15.c4.ctg.1	1878	12.0	0	.	p	.	0	E370trunc	TRUNC	1108	1108	G	967	967	T	3	T,G	1,2	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	474	parE_1	1893	1752	97.37	parE_1.l15.c4.ctg.1	1878	12.0	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1276	1278	AAC	15;16;16	A;A;C	15;16;16	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	474	parE_1	1893	1752	97.37	parE_1.l15.c4.ctg.1	1878	12.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1285	1287	GAT	16;16;16	G;A;T	16;16;16	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	515	474	parE_1	1893	141	98.58	parE_1.l15.c4.ctg.2	163	10.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	628	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1899	17.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	845	847	CAG	14;15;16	C;A;G	14;15;16	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	628	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1899	17.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1319	1321	GAT	23;24;24	G;A;T	23;24;24	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	V146F	0	.	.	436	438	GTT	613	615	GTT	21;21;21	G;T;T	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1714	1716	CAG	31;30;29	C;A;G	31;30;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1714	1716	CAG	31;30;29	C;A;G	31;30;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1753	1755	CAC	14;14;14	C;A;C	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1762	1764	CGT	14;15;15	C;G;T	14;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1762	1764	CGT	14;15;15	C;G;T	14;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1768	1770	TCC	14;14;14	T;C;C	14;14;14	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1774	1776	CTC	17;17;17	C;T;C	17;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1864	1866	ACC	19;18;18	A;C;C	19;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1867	1869	CCT	18;18;18	C;C;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1630	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4399	19.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2236	2238	CGT	25;24;24	C;G;T	25;24;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	.	n	.	0	A226G	SNP	226	226	A	372	372	G	155	G	154	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	A794G	0	.	.	794	794	A	940	940	A	110	A	109	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	A794T	0	.	.	794	794	A	940	940	A	110	A	109	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	G926A	0	.	.	926	926	G	1072	1072	G	146	G	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	G926T	0	.	.	926	926	G	1072	1072	G	146	G	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	G926C	0	.	.	926	926	G	1072	1072	G	146	G	145	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	A1519T	0	.	.	1519	1519	A	1665	1665	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	A1519C	0	.	.	1519	1519	A	1665	1665	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	1	SNP	n	A1519G	0	.	.	1519	1519	A	1665	1665	A	87	A	86	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	A79G	.	79	79	A	225	225	A	134	A,G	96,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	C719T	.	719	719	C	865	865	C	128	C,T	74,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	T273A	.	273	273	T	419	419	T	132	T,A	99,32	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	T1010C	.	1010	1010	T	1156	1156	T	120	T,C	66,50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	C1038T	.	1038	1038	C	1184	1184	C	122	C,T	72,50	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	C183T	.	183	183	C	329	329	C	104	C,T	75,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	T90C	.	90	90	T	236	236	T	133	T,C	101,29	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	A250T	.	250	250	A	396	396	A	144	A,T	106,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	G474A	.	474	474	G	620	620	G	134	G,A	97,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	A253T	.	253	253	A	399	399	A	145	A,T	108,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	C194T	.	194	194	C	340	340	C	107	C,T	80,25	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	G1002A	.	1002	1002	G	1148	1148	G	106	G,A	61,45	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	4248	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1700	125.1	0	HET	.	.	.	G1006C	.	1006	1006	G	1152	1152	G	111	G,C	62,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	242	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	915	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	158	soxR	465	465	100.0	soxR.l6.c4.ctg.1	824	10.0	1	SNP	p	R20H	0	.	.	58	60	CGC	199	201	CGC	15;15;15	C;G;C	15;15;15	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	158	soxR	465	465	100.0	soxR.l6.c4.ctg.1	824	10.0	1	SNP	p	G121D	0	.	.	361	363	GGT	502	504	GGT	9;10;10	G;G;T	9;10;10	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	120	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	758	8.4	1	SNP	p	A12S	0	.	.	34	36	GCA	260	262	GCA	15;16;16	G;C;A	15;16;16	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	278	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l15.c30.ctg.1	1153	12.7	0	.	p	.	0	E10K	NONSYN	28	30	GAA	157	159	AAA	8;9;9	A;A;A	8;9;9	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	539	316	APH_6__Id+	837	837	99.88	APH_6__Id+.l15.c4.ctg.1	1296	12.8	0	.	p	.	0	E47K	NONSYN	139	141	GAA	365	367	AAA	14;14;13	A;A;A	14;14;13	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	212	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1130	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	350	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1512	12.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	196	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1064	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	590	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1916	16.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
vgaC.3002831.KU302801.102199_102430.3686	vgaC.3002831.KU302801.102199_102430.3686	1	0	16	46	vgaC	231	156	98.08	vgaC.l15.c30.ctg.2	228	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	vgaC;vgaC is an efflux protein expressed in staphylococci that confers resistance to streptogramin A antibiotics and related compounds. It is associated with plasmid DNA.
